CD19 and leukemia: The observed contraction of B7-H3-CAR T cells was greater than we previously reported for CD19-CAR T cells in immune-competent leukemia animal models11, suggesting that persistence of Reg-1 KO CAR T cells is influenced by the tumor type and the associated microenvironment they are targeting.